Bartel has more than 25 years of leadership experience within the medical device and contract manufacturing industries. He has held various roles in leading marketing, business development and sales teams.
Most recently, Bartel was CEO and board member of Waltek, a private equity-owned casting and machining company in the medical industry, and was president of Spectralytics, a medical device contract manufacturing firm. He has also held leadership roles at Precision ADM and Stratasys.
“Vantage has been on an exciting growth journey, and I’m grateful for the opportunity to serve as CEO. We have a talented team of 150+ medical device engineers with decades of industry expertise. Their dedication to partnering with medical device innovators from concept to realization is what makes Vantage stand apart and is key to our long term success,” Bartel said in a news release.
Vantage MedTech provides design and manufacturing services for medical technology, from concept through to product realization. It partners with medtech startups and large medical device companies to offer feasibility support, product development and prototyping, clinical and commercial manufacturing and after-market services to support every phase of the product life cycle.
Vantage is backed by Ampersand Capital Partners.
“We are thrilled to have Jim join the Vantage team given his exceptional leadership qualities and deep understanding of contract services companies serving the medical device industry. His experience, commitment to quality, and teamwork mentality will prove invaluable to Vantage’s growth strategy,” Ampersand Partner Trevor Wahlbrink said.
